Compliance News Roundup: Reverse False Claims Act Webinar Q&A

Compliance News Roundup: Reverse False Claims Act Webinar Q&A

Posted by Healthicity
Jun 26, 2019 11:00:00 AM

1. The United States Intervenes In False Claims Act Lawsuit Against Drug Maker Mallinckrodt Alleging Illegal Kickbacks – “The United States filed a complaint under the False Claims Act against Mallinckrodt ARD LLC, formerly known as Mallinckrodt ARD Inc. and previously Questcor Pharmaceuticals Inc., in the U.S. District Court for the Eastern District of Pennsylvania, the Department of Justice announced today. The government alleges that Mallinckrodt and Questcor (collectively Mallinckrodt) engaged in conduct that violated the False Claims Act by using a foundation as a conduit to pay kickbacks in connection with its drug H.P. Acthar Gel (Acthar) from 2010 through 2014.” Get the full scoop >>

2. United States Files False Claims Act Complaint Against South Carolina Chiropractor, Pain Management Clinics, Urine Drug Testing Laboratories, and Substance Abuse Counseling Center – “The United States has filed a complaint under the False Claims Act against Daniel McCollum, a chiropractor based in Greenville, South Carolina, and pain management clinics and urine drug testing laboratories that McCollum owned or managed for engaging in illegal financial relationships and providing medically unnecessary services and items, including urine drug testing and steroid injections and prescriptions for opioids and lidocaine ointment, the Department of Justice announced today.” Get the full scoop >>

3. Deeper Than the Headlines: Reverse False Claims Act Webinar Q&A – We recently held a webinar on the Reverse False Claims Act and this week’s blog is in response to the Reverse False Claims Act webinar held on June 19th. Thanks again to everyone who tuned in. If you missed it, we highly recommend watching because we covered a lot of great stuff. But even if you missed it, you can find answers to some of your most pressing False Claims Act questions in this post. Get the full scoop >>

Questions or Comments?